Glenn G. Goddard

2021

In 2021, Glenn G. Goddard earned a total compensation of $4.1M as Executive Vice President, Chief Financial Officer and Treasurer at Intellia Therapeutics, a 159% increase compared to previous year.

Compensation breakdown

Bonus$234,752
Option Awards$2,683,389
Salary$419,200
Stock Awards$706,948
Other$9,060
Total$4,053,349

Goddard received $2.7M in option awards, accounting for 66% of the total pay in 2021.

Goddard also received $234.8K in bonus, $419.2K in salary, $706.9K in stock awards and $9.1K in other compensation.

Rankings

In 2021, Glenn G. Goddard's compensation ranked 3,314th out of 12,415 executives tracked by ExecPay. In other words, Goddard earned more than 73.3% of executives.

ClassificationRankingPercentile
All
3,314
out of 12,415
73rd
Division
Manufacturing
1,345
out of 5,505
76th
Major group
Chemicals And Allied Products
547
out of 2,375
77th
Industry group
Drugs
486
out of 2,096
77th
Industry
In Vitro and In Vivo Diagnostic Substances
9
out of 61
85th
Source: SEC filing on May 2, 2022.

Goddard's colleagues

We found four more compensation records of executives who worked with Glenn G. Goddard at Intellia Therapeutics in 2021.

2021

James Basta

Intellia Therapeutics

General Counsel

2021

John Leonard

Intellia Therapeutics

Chief Executive Officer

2021

Laura Sepp-Lorenzino

Intellia Therapeutics

Chief Scientific Officer

2021

David Lebwohl

Intellia Therapeutics

Chief Medical Officer

News

In-depth

You may also like